The Zucker Hillside Hospital
Glen Oaks, New York 11040
1 studies enrolling now · 29 studies all time
What they study most
Attenuated Psychosis Syndrome, Bipolar Disorder, Bipolar I Disorder, Bulimia Nervosa, Cannabis Dependence, Depression, Depressive Disorder, Depressive Disorder, Major, Eating Disorders, Electroconvulsive Therapy Treated Patients, Lorazepam, Negative Symptoms
Studies at this site
- Neural Biomarkers of Electroconvulsive Therapy Response — Recruiting now
- ERG Components in Schizophrenia and Bipolar Disorder Type I — Running, not enrolling
- 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide — Completed
- A Study of Paliperidone Palmitate 6-Month Formulation — Completed
- Deep Brain Stimulation for Major Depressive Disorder — Stopped early
- Adjunctive Vortioxetine in Schizophrenia — Status unconfirmed
- Fluoxetine vs Aripiprazole Comparative Trial (FACT) — Stopped early
- Financial Incentives to Improve Medication Adherence — Completed
- Lorazepam Effects on Neuroimaging Measures — Withdrawn before enrolling
- Safety and Effectiveness of D-serine in Schizophrenia — Completed
- Targeting Cognition in Bipolar Disorder With Pramipexole — Completed
- The Effect of Transcranial Direct Current Stimulation on Cognitive Side Effects of Electroconvulsive Therapy — Completed
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy — Completed
- Optimizing Response in Psychosis Study — Stopped early
- Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine — Completed
- Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole — Withdrawn before enrolling
- Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers — Completed
- A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features — Stopped early
- Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics — Completed
- Omega-3 Dietary Supplements in Schizophrenia — Completed
- The Assessment of Movement Disorders Utilizing Live Two-Way Video — Completed
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis — Completed
- Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade — Completed
- Liothyronine (T3) for Bipolar Depression — Completed
- A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder — Completed
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. — Completed
- Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania. — Completed
- A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents — Completed
- Topiramate for Binge Eating Disorder Among Adolescents — Completed